Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Microbiota-Gut-Brain Axis: From Motility to Mood

Gastroenterology(2021)10.1053/j.gastro.2020.10.066Source: DataRank Database

The Microbiota-Gut-Brain Axis: From Motility to Mood is a research paper published in Gastroenterology (2021). On theSindex it has a DataRank of 1.0. It has been cited 965 times.

N/A

1.0DataRank · unranked

Scored on demand from live citation data

Open Access965 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 71.21)OA: greenTopics (44)Linked Datasets (25)DataCite Reuse (25)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

1.0

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (3)

John F. Cryan ORCID,Emeran A. Mayer ORCID,Kara Gross Margolis ORCID

Live enrichment

PubMed:33493503 PMC:PMC8634751 OpenAlex:https://openalex.org/W3122128474

National Institutes of Health

Grant: RO1 NS015547

National Institutes of Health

Grant: R01 DK048351

U.S. Department of Defense

Grant: PR160365

Science Foundation Ireland

Grant: SFI/12/RC/ 2273_P2

NIDDK NIH HHS

Grant: R01 DK126644

NINDS NIH HHS

Grant: R01 NS015547

National Institutes of Health

Grant: 3R01DK048351-09S1

Perception and Modulation of Visceral Sensations

European Commission

Grant: 848228

Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in iRritable bowel syndrome In Europe

National Institutes of Health

Grant: 5R01NS015547-23

MICROENVIRONMENT IN ENTERIC NEURON DEVELOPMENT

FWCI

71.21

Citation Percentile

1.0%

Citation Trend

2017

2021

2022

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8634751

publisherhttps://api.elsevier.com/content/article/PII:S0016508521002687?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0016508521002687?httpAccept=text/plain

journalhttps://doi.org/10.1053/j.gastro.2020.10.066

Fields of Study

Diet and metabolism studiesGut microbiota and healthGastrointestinal motility and disorders0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Gastrointestinal MicrobiomeFecal Microbiota TransplantationAffectAnimalsBacteriaBrainCentral Nervous System DiseasesGastrointestinal DiseasesGastrointestinal MotilityHumansIntestinesDysbiosis

Keywords

MoodGut–brain axisMotilityGut floraNeuroscienceBiologyPsychologyCell biologyClinical psychologyBiochemistryirritable bowel syndromeMood DisordersBrain Gut AxisMicrobiota-gut-brain AxisBacteriaGastrointestinal DiseasesBrainFecal Microbiota TransplantationGastrointestinal MicrobiomeIntestinesAffectCentral Nervous System DiseasesAnimalsDysbiosisHumansGastrointestinal Motility

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat

10.6084/m9.figshare.16935668.v1figshare

Additional file 1 of Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat

10.6084/m9.figshare.16935668figshare

Additional file 2 of Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat

10.6084/m9.figshare.16935671.v1figshare

Additional file 2 of Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat

10.6084/m9.figshare.16935671figshare

Additional file 3 of Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat

10.6084/m9.figshare.16935674.v1figshare

Additional file 4 of Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat

10.6084/m9.figshare.16935677.v1figshare

Additional file 3 of Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat

10.6084/m9.figshare.16935674figshare

Additional file 4 of Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat

10.6084/m9.figshare.16935677figshare

Additional file 5 of Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat

10.6084/m9.figshare.16935680.v1figshare

Additional file 5 of Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat

10.6084/m9.figshare.16935680figshare

Additional file 1 of Effect of prebiotics, probiotics, synbiotics on depression: results from a meta-analysis

10.6084/m9.figshare.23606947figshare

Additional file 1 of Effect of prebiotics, probiotics, synbiotics on depression: results from a meta-analysis

10.6084/m9.figshare.23606947.v1figshare

Additional file 1 of Association between dietary inflammatory index and energy-adjusted dietary inflammatory index and constipation in US adults

10.6084/m9.figshare.26384662.v1figshare

Additional file 1 of Association between dietary inflammatory index and energy-adjusted dietary inflammatory index and constipation in US adults

10.6084/m9.figshare.26384662figshare

Additional file 6 of Causal relationship between gut microbiota and gastrointestinal diseases: a mendelian randomization study

10.6084/m9.figshare.26671281.v1figshare

Additional file 6 of Causal relationship between gut microbiota and gastrointestinal diseases: a mendelian randomization study

10.6084/m9.figshare.26671281figshare

Additional file 8 of Causal relationship between gut microbiota and gastrointestinal diseases: a mendelian randomization study

10.6084/m9.figshare.26671287.v1figshare

Additional file 8 of Causal relationship between gut microbiota and gastrointestinal diseases: a mendelian randomization study

10.6084/m9.figshare.26671287figshare

Additional file 1 of A meta-analysis of randomized controlled trials evaluating the effectiveness of fecal microbiota transplantation for patients with irritable bowel syndrome

10.6084/m9.figshare.26743745.v1figshare

Additional file 1 of A meta-analysis of randomized controlled trials evaluating the effectiveness of fecal microbiota transplantation for patients with irritable bowel syndrome

10.6084/m9.figshare.26743745figshare